Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Carlsmed Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Carlsmed Inc (CARL) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
59.58 %
Q2 2026
Net Margin
-55.49 %
Q2 2026

Key Findings: Carlsmed Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 62M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+21.3% annualized vs trailing 12 months).
  • Scale: Carlsmed Inc ranks #90 of 247 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.0% of industry market cap.
  • Peer revenue share: Carlsmed Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

CARL Sales vs. its Competitors, Q2 2026

Carlsmed Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/CARL/competitors
https://api.csimarket.com/api/v1/companies/CARL/relationships
https://api.csimarket.com/api/v1/companies/CARL/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs 59.6% for Carlsmed Inc. Carlsmed Inc's share of combined industry revenue moved from 0.01% to 0.02%, a gain of 0.00 percentage points.

Carlsmed Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Carlsmed Inc No Yes Yes -
Similar-Size Competitors (10) 30% 60% 40% 40%
Similar Growth & Profitability (8) 0.00 % (0 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 42.90 % (3 of 7)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

100%market share
  • Carlsmed Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Carlsmed Inc and its 0 tracked competitors.

See Carlsmed Inc's full market share breakdown »

CARL Stock Performance relative to its Competitors

CARL Competitors (weighted) Percent change over the selected range

Carlsmed Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
60%beat U.S.A. 500
Similar-Size
(6 of 10)
40%beat U.S.A. 500
Similar Growth & Profitability
(2 of 5)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Carlsmed Inc 11.50 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (10) 40.4% 63.2%
Similar Growth & Profitability (5) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Carlsmed Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

CARL Stock Performance relative to Similar-Size Competitors

CARL Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

CARL Stock Performance relative to Similar Growth & Profitability Competitors

CARL Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Carlsmed Inc's Comment on Competition and Industry Peers

The company operates in the medical device industry, facing competition from manufacturers of conventional spine and orthopedic devices as well as manufacturers of stock implants. Its business depends on contract manufacturing organizations (CMOs) for producing aprevo interbody implants, which may result in delays or supply challenges. Competitive pressures and advancements by other companies could impact the competitiveness of the aprevo Technology Platform and affect the company's business and prospects.